(Q36306185)

13 August 2017

Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children's Oncology Group (English)

1 reference

13 August 2017

1 reference

1 reference

4

Jamie Renbarger

1 reference

13 August 2017

5

Nita L Seibel

1 reference

13 August 2017

Bryan Langholz

1

1 reference

13 August 2017

Jeffrey M Skolnik

2

1 reference

13 August 2017

Jeffrey S Barrett

3

1 reference

13 August 2017

Anne Zajicek

6

1 reference

13 August 2017

Carola A S Arndt

7

1 reference

13 August 2017

language of work or name

1 reference

1 December 2010

1 reference

13 August 2017

Pediatric Blood Cancer

1 reference

13 August 2017

57

1 reference

13 August 2017

2

1 reference

13 August 2017

252-257

1 reference

Vincristine: Can its therapeutic index be enhanced?

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467305

Population pharmacokinetic investigation of actinomycin-D in children and young adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467305

Selective metabolism of vincristine in vitro by CYP3A5.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467305

Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467305

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467305

Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPBC.22882

Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPBC.22882

Vincristine pharmacokinetics after repetitive dosing in children.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPBC.22882

Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents

21 January 2018

1 reference

12 December 2020

Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group

1 reference

12 December 2020

Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group

1 reference

12 December 2020

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients

1 reference

12 December 2020

Identifiers

DOI

10.1002/PBC.22882

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

21671362

1 reference